We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Filters

Equity Crowdfunding Pitches

Showing results
ENSO is developing a new generation of cleaner, sustainable tyres and plans to disrupt the £200 billion global tyre market. It argues that conventional tyres are largely made of fossil fuels and contribute up to 28%+ of all primary ocean microplastics upon wearing down. It further points out that the increased weight and torque of electric vehicles wears tyres even faster, emitting more pollution. ENSO is addressing this crisis by developing sustainable tyres for EVs, to help reduce carbon emissions in line with the UK Government’s 'Net-Zero Strategy'. Its business is built on a direct-to-customer ‘Pay-per-Mile’ model serving EV-carmakers, fleets and private individuals directly. It claims that its latest energy-efficient tyres have achieved ‘A’ energy efficiency ratings by TÜV SÜD in Germany. The company will use the investment to deliver its first commercial tyres to EV-carmakers in 2021, and launch trials via London FreightLab, with Transport for London and DPD, with plans to expand to California by 2022.
days to go: Expired investment: £1,873,760
Pavegen is at the forefront of transforming cities through groundbreaking kinetic technology that converts foot traffic into renewable energy and valuable data. Their impressive 100% revenue growth in 2022, reaching £2 million with an EBITDA of -£627,000, has spurred them to seek funding to capitalize on the rapidly expanding ESG market, anticipated to be worth $50 trillion by 2025. With the pressing need for climate action, Pavegen's solution revolves around generating off-grid energy and data from urban foot traffic, fundamentally reshaping how cities and institutions interact with renewable energy sources and engage with their communities, contributing to a more sustainable planet. Their business model includes large-scale installations, revenue generated from their data platform and analytics, and multiple income streams. In a competitive landscape, Pavegen is a pioneering market leader, offering an efficient means of harnessing energy from motion through their core IP electromagnetic technology. The raised funds will support the expansion of sales and marketing efforts, technology scaling, and innovation, including the development of new products such as kinetic roads. Pavegen has gained the support of institutional investors like the Hinduja Group and Tamar Capital, propelling urban transformation. They serve a diverse customer base globally, including blue-chip companies, governmental bodies, and various entities in 37 countries. Pavegen holds three international patents, positioning them as a trailblazer in kinetic energy technology with applications in various fields.
days to go: Expired investment: £1,860,345
A current account for small business owners and the self-employed that automates their accounting and taxes. Coconut informs customers about transactions on their account that that are eligible for a tax deduction and automatically completes a tax return. It also provides a tax bill forecast and shows guidance on tax rules and regulations. Coconut currently looks after 3,000 accounts and has pre-registered 5,000 limited companies with total transactions processed exceeding £12m.
days to go: Expired investment: £1,857,450
The Wild Beer Co have created a Wildly Different beer by using wild fermentation and barrel aging. They have fused beer with different tastes such as fruit flavours, sours, herbal, spicy and even using smoke techniques to flavour the beer. 
days to go: Expired investment: £1,760,340
TC BioPharm is an immunotherapy company. It has used its patented technology to harness the power of a particular part of the immune system, Gamma Delta T-cells (GDT), to negate cancer cells in the human body. TC BioPharm has treated terminally ill patients with acute myeloid leukaemia in approved clinical trials garnering positive responses from multiple patients. The company has received regulatory approval from the Medicines and Healthcare products Regulatory Agency (MHRA) to run a COVID-19 clinical trial to address the global pandemic. TC BioPharm aims to use its current technology to provide a frozen product that can be manufactured cost-effectively and distributed globally. The company has already raised over £7 million in the last 15 months. It will use the investment to take its clinical trials forward in COVID-19 and cancer.

Pitch Rated

59%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £1,753,067
Tribe are a modern, natural nutrition brand, based online and tailored to the customer. The UK sport nutrition market is growing at 23% a year and Tribe have already gained 25,000 members purchasing products from them. All products are formulated for performance and made from the highest natural ingredients. 
days to go: Expired investment: £1,747,470
Gozney specialises in the designing and manufacturing of premium and creative stone & fire ovens for the commercial and home use. The company has invented the world’s first portable stone pizza oven, 'Roccbox' and made $1.2M pre-sales in 45 days. In 2018-19, it has received revenue of £5.4M and EBITDA of £0.2M. Gozney ovens are used by leading restaurant chains including MOD, Franco Manca and many more. Recently, the company has been ranked at No. 12 in the 5th annual Sunday Times WorldFirst SME Export Track 100. Gozney has witnessed a growth of 148% in international sales over the past 2 years. Furthermore, it aims to launch new products and accelerate expansion into overseas territories.
days to go: Expired investment: £1,716,200
Callaly is the UK’s first female care B-Corp that delivers subscription-based organic cotton period products. The company has invented and patented the 'Tampliner', a combination of an organic cotton tampon with a soft mini-liner for built-in leak protection, with a clean insertion and removal, and no hard plastic applicator. It is multi-patented in 30 countries. The company has developed bespoke robotic machinery to automate production at a UK facility. In a £26 billion global femcare market, Callaly claims that its potential tampliner market would constitute 2% to 4% by 2024. The company has received rave reviews from magazines such as Cosmopolitan and Grazia. Callaly plans to begin sales in Europe in the third quarter of 2020 followed by sales in the US and Asia in 2021.
days to go: Expired investment: £1,704,460
ikigai aims to be the first financial technology company in the UK to combine banking and wealth management in one app, helping young affluents grow their money. It argues that 56% of high-net-worth millennials are dissatisfied with the wealth management tools on offer. ikigai aims to change that. It allows users to plan a variety of financial goals such as building wealth, starting a new business, or purchasing a home, to name a few. The company has partnered with Blackrock, which provides asset allocation insights to users. ikigai has raised £2 million to date and launched on iOS. The company has featured in media entities like TechCrunch, UKTN, AltFi and Glamour. It has partnered with best-in-class providers like WealthKernel and Railsbank. It will use the investment to grow its technology team and product roadmap.
days to go: Expired investment: £1,675,801
Opened in 2014, The Lakes Distillery has sold over 160,000 bottles of their premium gin, vodka, and blended whisky; voted one of the top 5 best new distilleries in the world.
days to go: Expired investment: £1,620,110
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph